291 related articles for article (PubMed ID: 25237891)
1. Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension.
Kaur G; Singh N; Samuel SS; Bora HK; Sharma S; Pachauri SD; Dwivedi AK; Siddiqui HH; Hanif K
Pharm Biol; 2015 Jan; 53(1):147-57. PubMed ID: 25237891
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats.
Gupta A; Singh S
Pharm Biol; 2014 Mar; 52(3):308-20. PubMed ID: 24188460
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
5. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats.
Rasool M; Varalakshmi P
Fundam Clin Pharmacol; 2007 Apr; 21(2):157-64. PubMed ID: 17391288
[TBL] [Abstract][Full Text] [Related]
7. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
10. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
Wang Y; Zhang XH; Wang HL
Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
[TBL] [Abstract][Full Text] [Related]
11. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
12. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
14. Allicin in garlic protects against coronary endothelial dysfunction and right heart hypertrophy in pulmonary hypertensive rats.
Sun X; Ku DD
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2431-8. PubMed ID: 16731642
[TBL] [Abstract][Full Text] [Related]
15. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
Hacker AD
Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
Sun X; Ku DD
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H801-9. PubMed ID: 18055512
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
18. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction.
Mohanty I; Arya DS; Dinda A; Talwar KK; Joshi S; Gupta SK
Basic Clin Pharmacol Toxicol; 2004 Apr; 94(4):184-90. PubMed ID: 15078343
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
Yavuz T; Uzun O; Macit A; Comunoglu C; Yavuz O; Silan C; Yuksel H; Yildirim HA
Pathol Res Pract; 2013 May; 209(5):302-8. PubMed ID: 23582365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
